MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp. (OTCBB: RBCC) is well-positioned to capitalize on the revolution in medicine being spurred on by 3D printing technology thanks to the innovative BiO Assay, a new 3D bioprinting system developed by RBCC’s joint venture partner, Nano3D Biosciences (n3D).
Help employers find you! Check out all the jobs and post your resume.